Stanley Druckenmiller (Duquesne Family Office) other Viking Therapeutics, Inc.
Stanley Druckenmiller (Duquesne Family Office) other $14.6K of disclosed value in Viking Therapeutics, Inc..
Signal
Investor Move
Action
Other
Capital
$14.6K disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.